Clinical Trial

Guangzhou Preterm and Term Birth Cohort Study

Study acronym: GPTBC
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The Guangzhou Preterm-Term Birth Cohort (GPTBC) is a prospective observational study of how early-life nutrition, environmental exposures, and family factors relate to the health and development of preterm and term infants and their mothers. Mother-infant pairs are followed from birth to 24 months. Researchers use questionnaires and biological samples to study human milk, microorganisms in the infant gut, physical growth, development, and allergic diseases, and whether these relationships differ between preterm and term infants. Findings may inform nutrition and health strategies for infants born at different gestational ages.
Trial Details
NCT Number NCT07756177
Lead Sponsor Sun Yat-sen University
Collaborators: The Third Affiliated Hospital of Guangzhou Medical University
Conditions Preterm Birth, Neurodevelopmental Disorders, Overweight, Obesity, Allergic Diseases
Enrollment 200 participants
Start Date 2023-11-21
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-10